As of March 2026 Alnylam Pharmaceuticals has a market cap of โฌ37.40 Billion. This makes Alnylam Pharmaceuticals the world's 564th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 28th, 2026 the market cap of Alnylam Pharmaceuticals was reported to be: